# Middle Meningeal Artery Embolization With Liquid Embolic Agent for Treatment of Chronic Subdural Hematoma

> **NCT04574843** · NA · UNKNOWN · sponsor: **Mashhad University of Medical Sciences** · enrollment: 100 (estimated)

## Conditions studied

- Chronic Subdural Hematoma

## Interventions

- **PROCEDURE:** Embolization of MMA

## Key facts

- **NCT ID:** NCT04574843
- **Lead sponsor:** Mashhad University of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-08-01
- **Primary completion:** 2023-12-31
- **Final completion:** 2024-03-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2023-05-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04574843

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04574843, "Middle Meningeal Artery Embolization With Liquid Embolic Agent for Treatment of Chronic Subdural Hematoma". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04574843. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*